← Back to Search

Patients with suspected or confirmed pediatric solid tumors for Pediatric Cancer

N/A
Recruiting
Research Sponsored by Giselle SaulnierSholler
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 years
Awards & highlights
No Placebo-Only Group

Summary

This is an observational data registry study of pediatric cancer patients at participating Beat Childhood Cancer Consortium sites involving specimen banking and data collection.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Create a data registry of clinical and molecular/genomic data
Determine number and types of genomic alterations within tumor types/subtypes
Evaluate the correlation of baseline genomic alterations with clinical outcome.
+1 more
Secondary study objectives
Bank additional specimens available for future research projects
Create cell line and xenograft models of pediatric cancers for future research

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients with suspected or confirmed pediatric solid tumorsExperimental Treatment1 Intervention
Patients with suspected or confirmed pediatric solid tumors

Find a Location

Who is running the clinical trial?

Giselle SaulnierShollerLead Sponsor
21 Previous Clinical Trials
1,905 Total Patients Enrolled
Giselle ShollerLead Sponsor
22 Previous Clinical Trials
1,990 Total Patients Enrolled
Wake Forest University Health SciencesLead Sponsor
1,359 Previous Clinical Trials
1,039,299 Total Patients Enrolled
~314 spots leftby Jan 2031